Success Metrics

Clinical Success Rate
84.1%

Based on 37 completed trials

Completion Rate
84%(37/44)
Active Trials
89(55%)
Results Posted
11%(4 trials)
Terminated
7(4%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

80.4%

37 of 46 finished

Non-Completion Rate

19.6%

9 ended early

Currently Active

89

trials recruiting

Total Trials

163

all time

Status Distribution
Active(106)
Completed(37)
Terminated(9)
Other(11)

Detailed Status

Recruiting81
Completed37
Not yet recruiting9
unknown9
Active, not recruiting8
Enrolling by invitation8

Development Timeline

Analytics

Development Status

Total Trials
163
Active
89
Success Rate
84.1%

Trials by Status

not_yet_recruiting96%
terminated74%
active_not_recruiting85%
enrolling_by_invitation85%
suspended21%
recruiting8150%
unknown96%
completed3723%
withdrawn21%

Recent Activity

Clinical Trials (163)

Showing 20 of 163 trialsScroll for more
NCT06880861

Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers

Recruiting
NCT07215624

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

Recruiting
NCT07850284

SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders

Recruiting
NCT07212491

Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma

Enrolling By Invitation
NCT06472817

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

Enrolling By Invitation
NCT05908682

Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes

Recruiting
NCT06784167

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

Recruiting
NCT07186699

Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD

Recruiting
NCT06271291

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Recruiting
NCT07823283

Continuous Monitoring of Microvascular Anastomoses: An Observational Trial

Recruiting
NCT06584396

Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study

Active Not Recruiting
NCT06630338

Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements

Not Yet Recruiting
NCT06002828

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Active Not Recruiting
NCT07003100

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Recruiting
NCT06192875

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

Recruiting
NCT06067295

Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Recruiting
NCT06562777

Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

Recruiting
NCT06482073

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care

Recruiting
NCT07412002

Quality of End-of-Life Care for Children With Cancer

Recruiting
NCT06470750

Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP)

Completed

Drug Details

Intervention Type
OTHER
Total Trials
163